Bromide

Bromide

SCHEMBL8005944

Br.COc1cc(Cn2cncc2COC(C)=O)ccc1C#N

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 5/20 0.56
▸ CYP11B2 P19099 5/20 0.56
▸ FNTA P49354 9/20 0.45
▸ FNTB P49356 9/20 0.45
▸ PGGT1B P53609 9/20 0.45
▸ CACNA1H O95180 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7194363 0.99 CYP11B1 (0.57) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL7654511 0.87 CYP11B1 (0.51) CYP11B1CYP11B2FNTAFNTBPGGT1B
Bromide SCHEMBL6409239 0.87 CYP11B1 (0.54) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL7163166 0.85 CYP11B1 (0.55) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL3501397 0.84 FNTA (0.58) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL7187666 0.84 CYP11B1 (0.60) CYP11B1CYP11B2FNTAFNTBPGGT1B
Hydrochloric Acid SCHEMBL2789879 0.83 CYP11B1 (0.47) CYP11B1CYP11B2FNTAFNTBPGGT1B
Hydrochloric Acid SCHEMBL7970012 0.83 FNTA (0.57) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL7658010 0.82 CYP11B1 (0.53) CYP11B1CYP11B2FNTAFNTBPGGT1B
Bromide SCHEMBL7574960 0.82 CYP11B1 (0.49) CYP11B1CYP11B2FNTAFNTBPGGT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000059930-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 2000-10-12 — — WO disclosed
US-6103487-A DETECTING MODULATORS THAT SUPPRESS THE ACTIVITY OF A TRANSFERASES; ANTICARCINOGENIC AGENTS MERCK & CO., INC. (US) 2000-08-15 — — US disclosed
WO-2000025789-A1 A METHOD OF TREATING ENDOMETRIOSIS MERCK & CO., INC. (US) 2000-05-11 — — WO disclosed
Send feedback